Cargando…
Cholinergic anti-inflammatory pathway and COVID-19
[Image: see text] The cholinergic anti-inflammatory pathway (CAP) first described by Wang et al, 2003 has contemporary interest arising from the COVID-19 pandemic. While tobacco smoking has been considered an aggravating factor in the severity of COVID-19 infections, it has been suggested by some th...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tabriz University of Medical Sciences (TUOMS Publishing Group)
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905591/ https://www.ncbi.nlm.nih.gov/pubmed/35411295 http://dx.doi.org/10.34172/bi.2022.23980 |